DLF Reports Marginal Decline in Q4 Profit as Revenue Drops 42 Board Recommends Rs 8 Dividend Sangamo Therapeutics Draws Renewed Investor Attention Amid Biotech Sector Interest SHF Holdings SHFS Surges 279 Nearing 047 Resistance 20260514